Works matching IS 0008543X AND DT 2022 AND VI 128 AND IP 22

Results: 19
    1
    2
    3
    4

    Blood-based test to predict future risk of developing liver cancer: Researchers recently discovered a genetic signature that can help predict long-term hepatocellular carcinoma risk in patients who have nonalcoholic fatty liver disease, and may also help monitor therapy effectiveness and differentiate screening necessity for these patients: Researchers recently discovered a genetic signature that can help predict long-term hepatocellular carcinoma risk in patients who have nonalcoholic fatty liver disease, and may also help monitor therapy effectiveness and differentiate screening necessity for these patients.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 22, p. 3904, doi. 10.1002/cncr.34523
    By:
    • Nierengarten, Mary Beth
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Model for regional collaboration: Successful strategy to implement a pediatric early warning system in 36 pediatric oncology centers in Latin America.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 22, p. 4004, doi. 10.1002/cncr.34427
    By:
    • Agulnik, Asya;
    • Gonzalez Ruiz, Alejandra;
    • Muniz‐Talavera, Hilmarie;
    • Carrillo, Angela K.;
    • Cárdenas, Adolfo;
    • Puerto‐Torres, Maria F.;
    • Garza, Marcela;
    • Conde, Tania;
    • Soberanis Vasquez, Dora J.;
    • Méndez Aceituno, Alejandra;
    • Acuña Aguirre, Carlos;
    • Alfonso, Yvania;
    • Álvarez Arellano, Shillel Yahamy;
    • Argüello Vargas, Deiby;
    • Batista, Rosario;
    • Blasco Arriaga, Erika Esther;
    • Chávez Rios, Mayra;
    • Cuencio Rodríguez, María Elena;
    • Fing Soto, Ever Amilcar;
    • Gómez‐García, Wendy
    Publication type:
    Article
    18

    Issue Information.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 22, p. 3897, doi. 10.1002/cncr.33026
    Publication type:
    Article
    19

    Posttransplant cyclophosphamide‐based anti–graft‐vs‐host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen‐mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 22, p. 3959, doi. 10.1002/cncr.34452
    By:
    • Nagler, Arnon;
    • Labopin, Myriam;
    • Arat, Mutlu;
    • Reményi, Péter;
    • Koc, Yener;
    • Blaise, Didier;
    • Angelucci, Emanuele;
    • Vydra, Jan;
    • Kulagin, Aleksandr;
    • Socié, Gerard;
    • Rovira, Montserrat;
    • Sica, Simona;
    • Aljurf, Mahmoud;
    • Gülbas, Zafer;
    • Kröger, Nicolaus;
    • Brissot, Eolia;
    • Peric, Zinaida;
    • Giebel, Sebastian;
    • Ciceri, Fabio;
    • Mohty, Mohamad
    Publication type:
    Article